Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 226.22M P/E - EPS this Y -101.70% Ern Qtrly Grth -
Income -308.46M Forward P/E -1.66 EPS next Y 55.60% 50D Avg Chg -22.00%
Sales 72.68M PEG -0.04 EPS past 5Y - 200D Avg Chg -59.00%
Dividend N/A Price/Book N/A EPS next 5Y 16.90% 52W High Chg -80.00%
Recommedations 2.80 Quick Ratio 1.60 Shares Outstanding 29.08M 52W Low Chg 12.00%
Insider Own 1.77% ROA -66.52% Shares Float 26.87M Beta 0.89
Inst Own 89.96% ROE - Shares Shorted/Prior 8.86M/7.97M Price 7.78
Gross Margin -80.44% Profit Margin - Avg. Volume 1,224,257 Target Price 15.91
Oper. Margin -348.66% Earnings Date Feb 21 Volume 1,288,519 Change 1.17%
Esperion Therapeutics, Inc. News
11/19/21 Implied Volatility Surging for Esperion Therapeutics (ESPR) Stock Options
11/12/21 Esperion Presents Important New Science Highlighting Potential Benefits of NEXLETOL® (bempedoic acid) Tablets at American Heart Association Scientific Sessions 2021
11/06/21 Esperion Therapeutics, Inc. (NASDAQ:ESPR): Are Analysts Optimistic?
11/02/21 Esperion Therapeutics, inc (ESPR) Q3 2021 Earnings Call Transcript
11/02/21 Esperion (ESPR) Beats on Q3 Earnings, Lowers Expense Guidance
11/02/21 Esperion Therapeutics (ESPR) Reports Q3 Loss, Tops Revenue Estimates
11/02/21 Esperion Reports Third Quarter 2021 Financial Results and Provides Company Update
11/01/21 Esperion to Present Key Science at the American Heart Association Scientific Sessions 2021
11/01/21 Esperion Announces the Appointment of Seth H.Z. Fischer to its Board of Directors
03:01 PM Esperion to Participate in Upcoming Virtual Investor Conference
10/26/21 Esperion Therapeutics (ESPR) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
10/25/21 Why Esperion Therapeutics Plummeted by 11% Today
10/25/21 ESPERION Announces Agreement to Exchange $15 Million in Principal Amount of its 4.00% Convertible Senior Subordinated Notes due 2025 for Common Stock
10/19/21 Esperion (ESPR) to Cut 40% Workforce, Revamp Cost Structure
10/18/21 Esperion Chops 40% Workforce As Launch Of Cholesterol Medication Falters
10/18/21 Esperion Plans Expense & Operational Structure Alignment; Shares Fall 1.5% Pre-Market
10/18/21 Esperion Therapeutics to reduce workforce by 40%
10/18/21 ESPERION Announces Plan for Transformative Long-Term Growth
10/12/21 Esperion to Report Third Quarter 2021 Financial Results November 2, 2021

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low-density lipoprotein cholesterol in the United States and internationally. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

ESPR Chatroom

User Image OOO_Mystery Posted - 17 hours ago

$ESPR short squeeze

User Image Mrmarvinmartian Posted - 22 hours ago

$ESPR By my calculations whatever event has caused volume ramp up would have to be disclosed by Monday, which would be 4 business days since we began noticing the surge. That surge in SP on Tuesday sure felt like BO, but the dump on Wednesday has me thinking absolutely not. Somebody call the mystery machine and let those meddlesome kids get to the bottom of this.

User Image Mrmarvinmartian Posted - 22 hours ago

$ESPR Dayymm. This green is a surprise. More than average volume on a half day that is lightly traded. And again, no news. Whatever happened to the 'seller disclose' legal frame work underpinning securities markets.

User Image VeilLiftFinance Posted - 22 hours ago

$ESPR we like the stock ? 4.76 days to cover according to fintel…

User Image Gary9912 Posted - 23 hours ago

$ESPR I sold a portion of shares here to offset some earlier 2021 gains. Waiting for a month was difficult especially watching that big buy that triggered that 40% jump the other day but I was able to jump back in this morning and hoping we can get some news soon. Hey big buyer in case you’re planning another huge buy minutes before the closing bell today, I just wanted to let you know that the market is closing at 1PM today, so have at it. 😜

User Image BidaskBot Posted - 1 day ago

EsperionTherapeutics $ESPR BidaskScore is #Reiterated to StronglySold https://bidaskclub.com/news/company/2021-11-24/ESPR

User Image Bmac2020 Posted - 1 day ago

$ESPR so we have a lot of alumni of pharm buyouts here. In the past did volume go way up and down right before the buy out? Hopefully this will be my first.

User Image SweepCast Posted - 1 day ago

SweepCast alerted: $ESPR with Unusual Options Activity Alerted on $10 PUT Expiring: 01-21-2022 worth 25K🐻 |🥇 Learn How Unusual Options Helps Gain Insights! www.sweepcast.com 🥇 |

User Image parampal Posted - 1 day ago

$ESPR Does anyone know what happened with this BO deal with $PFE in 2003. Hope this happens for real now 🤔

User Image travis305182 Posted - 1 day ago

$ESPR $5.

User Image timfris Posted - 1 day ago

$ESPR wonder what that big move was other day? Maybe someone got wind of a BO offer? Who know, but that’s really their only option left. Might not be a bad gamble but I can’t buy any for 3 more weeks or so.

User Image shortablestocks Posted - 1 day ago

$ESPR is short sale restricted for 2021-11-26. https://www.shortablestocks.com/?ESPR

User Image Mrmarvinmartian Posted - 1 day ago

$ESPR Pre-market volume on the high side again at almost 400,000 shares. And still no news. 🤷‍♂️

User Image MrShort Posted - 1 day ago

$ESPR Estimated S.I as on 11/24/21 31.73 Percent Not all the Shorts with S.I squeeze, the price moment, average days the shorts on loan, average price the stock was shorted plays significant roles – I update the spread sheet based on everyday stock moment and estimate how much loss the shorts are in every day. This will help to understand the likely short squeeze, higher the losses the Shorts are in – more likely the squeeze would happen, not just the S.I %age itself. Please visit my home page for more information. *The content provided in post is for information purpose only – please do you due diligence before investing.

User Image _chet_ Posted - 1 day ago

$ESPR BO happening?

User Image Gary9912 Posted - 1 day ago

$ESPR Ok, sure we will ask our loved ones about their next cholesterol check.🤦‍♂️ You should also be advising all shareholders to get their blood pressure checked, especially longterm shareholders, supporting Esperion can be very stressful and hazardous to your health. 📉 😳😫😬🆘 Happy Thanksgiving 🦃 all, yeah you too Esperion, we are still holding out hope that you’re gonna work a miracle deal for us all.🙏 (sooner rather than later please)

User Image tickeron Posted - 2 days ago

Oh wow this is big! $ESPR in +5.34% Uptrend, advancing for three consecutive days on November 3, 2021. View odds for this and other indicators: https://srnk.us/go/3186840

User Image ChartMill Posted - 2 days ago

$ESPR was analyzed by 17 analysts. The buy consensus is at 71%. So analysts seem to be mildly confident about $ESPR. https://www.chartmill.com/stock/analyzer/stock/ESPR?view=analyst-ratings&utm_source=stocktwits&utm_medium=ANALYST&utm_content=ESPR&utm_campaign=social_tracking

User Image SweepCast Posted - 2 days ago

SweepCast alerted: $ESPR with Unusual Options Activity Alerted on $10 PUT Expiring: 01-21-2022 worth 25K🐻 |🥇 Learn How Unusual Options Helps Gain Insights! www.sweepcast.com 🥇 |

User Image stocktowatch7 Posted - 2 days ago

$ESPR, $GGB here goes on http://www.stocksequity.com/active-stocks/sector-percentage-losers-esperion-therapeutics-inc-nasdaqespr-gerdau-s-a-nyseggb/

User Image talltom Posted - 2 days ago

$ESPR My numbers show live cash est $76,402,056 Cash burn $23,056,333 So they have till Feb or maybe middle of March to either sell or a secondary offering.

User Image talltom Posted - 2 days ago

$WISH Another $ESPR what u guys holding?

User Image jember Posted - 2 days ago

Other than these last 2 days, average daily trading volume for $ESPR this year is 800K shares/day. In the last 23 months, from beginning of January 2020 (before FDA approval), here are the biggest volume days: 11/24/21 - 6.66M shares - TODAY. NO NEWS. TOTAL MYSTERY. 5/5/21 - 6.34M shares - Stifel downgrade where they said ‘bull case is off the table,’ and ‘lackluster sales ramp’. Damn he was right! Except he only lowered PT to $20, should've been to $7. 11/21/21 - 5.02M shares - YESTERDAY. NO NEWS. TOTAL MYSTERY. 1/24/21 - 4.82M shares - This was probably Gamestop short squeeze or news of BO talks leaked. 11/3/20 - 4.46M - 2020Q3 earnings. Here's another stat. The highest 3-day volume in past 2 years was on 5/7/21 with 8.7M after the Stifel downgrade. Now, in just the last 2 days, it's more than 11.68M shares. That's more than 40% of company shares that have traded on NO NEWS at all. Nothing in weeks.

User Image Mrmarvinmartian Posted - 2 days ago

$ESPR 6 million in volume today.

User Image stocksarelit Posted - 2 days ago

$ESPR What else should we have expected? Nothing but games to be played with morons Koenig and Bartram at the helm.

User Image Investmann Posted - 2 days ago

$ESPR will explode

User Image sepsis74 Posted - 2 days ago

$ESPR the shares were $10 just at the beginning of November. Without any news, it fell to $7. Certainly the share price fall has outpaced the pace of cash burn in the past 6 months. There isn't much rhyme or reason to why it is so cheap, along with dozens of other small biotechs, other than it seems like YTD losers to November have been crushed, maybe because of tax-loss selling or some other non-fundamental reasons. Healthcare hedge funds are beginning to buy the dip.

User Image Gary9912 Posted - 2 days ago

$ESPR Just throwing this out there, not trying to suggest anything. So I have only been involved in two buyouts and they were straight forward. Could it be possible that this company that is struggling for cash and has this blockbuster product that could/should produce positive CVR results next year agree to a buyout that has an incentive for a later positive CVR (so not to just give away the company’s value) like was done with FLXN, almost double will be awarded if CVR is positive in that agreement. I’m not suggesting that’s what’s going on but, those with experience in this, do you think it’s a possibility? And if so how does that work, would you have to hold the shares all the way through till CVOT completes. 🤷‍♂️

User Image cparma Posted - 2 days ago

$XL jumping in on this one. Also watching $IINN $ESPR $GOCO. Holding $GENI

User Image petr007 Posted - 2 days ago

$ESPR another 40% up please

Analyst Ratings
Credit Suisse Neutral Oct 19, 21
Morgan Stanley Underweight Oct 14, 21
Morgan Stanley Equal-Weight Aug 4, 21
Needham Strong Buy Aug 3, 21
Credit Suisse Outperform May 5, 21
Northland Capital Markets Market Perform May 5, 21
Morgan Stanley Equal-Weight May 5, 21
JMP Securities Market Outperform May 5, 21
Stifel Hold May 5, 21